$4.88-0.06 (-1.21%)
Modular Medical, Inc.
Modular Medical, Inc. in the Healthcare sector is trading at $4.88 with a market capitalization of $25M. The stock is currently near its 52-week low of $3.13, remaining 55.1% below its 200-day moving average. On fundamentals, Piotroski 5/9 shows mixed financial quality, Altman Z in the distress zone. Risk note: MACD remains below its signal line. The Whystock Score of 30/100 signals elevated caution as multiple indicators diverge.
| Metric (USD) | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|---|
| Total Revenue | $0 | $0 | $0 | $0 | $0 |
| Gross Profit | — | — | — | — | — |
| Operating Income | -$7.24M↑ | -$7.83M↓ | -$6.80M↓ | -$4.98M↓ | -$4.85M |
| Net Income | -$7.36M↑ | -$7.79M↓ | -$6.70M↓ | -$4.93M↓ | -$4.80M |
Modular Medical, Inc. operates as a medical device company. The company focuses on the design, development, and commercialization of insulin pumps. It also offers MODD1, a two-part patch pump for type-1 and type-2 diabetes. Modular Medical, Inc. is h...
Investing.com - Qualcomm (NASDAQ:QCOM) unveiled its Dragonfly C1000 data center CPU and secured Meta Platforms as its first major customer, announcing a strategic multi-generation supply agreement at its Investor Day 2026 in New York City.
Modular Medical, Inc. (NASDAQ:MODD) said its Pivot tubeless insulin patch pump is now commercially available in the U.S., marking its transition to a commercial-stage medical device company. The launch also represents the beginning of real-world patient use of the company’s insulin delivery platform. The FDA approved the insulin pump in June. Read Also: Diabetes Focused MiniMed Recovery Story Builds As Pipeline Improves Pivot Designed To Simplify Insulin Delivery The company on Wednesday said th
Modular Medical (MODD) announced the start of production of validation lots for its Pivot tubeless patch pump’s disposable cartridge and infusion set. Achievement of this manufacturing milestone keeps the Company on schedule for commercial launch in Q1 2026, subject to receipt of FDA 510(k) clearance. “We are excited to hit this pivotal manufacturing validation on schedule, bringing us closer to delivering our Pivot pump’s game-changing simplicity to patients underserved by current options,” sai
Viewing insider transactions for Modular Medical, Inc.'s ( NASDAQ:MODD ) over the last year, we see that insiders were...